It is a pharma private limited company based in Rudrapur, Uttarakhand, India, established in 2014.
2014 | Rudrapur, Uttarakhand, India | ActiveAlmonair Laboratories Private Limited, a active private limited company, was established on 10 April 2014 in Rudrapur, Uttarakhand, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24200UR2014PTC001122. Registered under ROC Roc Uttarakhand. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.65 M.
It upholds a compliant status. Its leadership includes Pravesh Gangwar (Director), Chandra Prakash Gangwar (Director). Past directors included Ashish Jouhari, Pravesh Gangwar, Anuradha Saxena. It holds ₹1.10 M open charges and no settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at Village Lamra Shimla Bahadur, Rudrapur, Uttarakhand, 263153.
U24200UR2014PTC001122
001122
10 April 2014
₹1.00 M
₹0.65 M
Roc Uttarakhand
Unlisted
Active
Explore comprehensive insights into Almonair Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pravesh Gangwar | Director | 28 Jan 2016 | Current |
| Chandra Prakash Gangwar | Director | 10 Apr 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 18 Jan 2016 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2016 | Past |
| Pramod Abcsdd | Director | 28 Jan 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Almonair Laboratories Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 1.81% decrease. The company also saw a substantial fall in profitability, with a 51.65% decrease in profit. The company's net worth moved up by a moderate rise of 6.45%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Almonair Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,104,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Jul 2020 | Others | ₹0.17 M | Open |
| 16 Dec 2017 | Others | ₹0.94 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Almonair Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Almonair Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Almonair Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Almonair Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was documented.
Almonair Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Uttarakhand. was recorded as a recent event.
A charge with Others amounted to Rs. 0.17 M with Charge ID 100347699 was registered on 01 Jul 2020. was recorded as a recent event.
The activity A charge with Others of Rs. 0.94 M registered on 16 Dec 2017 with Charge ID 100146979 was modified on 12 May 2020. was completed.
The activity A charge with Others amounted to Rs. 0.94 M with Charge ID 100146979 was registered on 16 Dec 2017. was completed.
Progress on Pravesh Gangwar was appointed as a Director was appointed as a Director on 28 Jan 2016 & has been associated with this company since 9 years 10 months . was documented.
The CIN of Almonair Laboratories Private Limited is U24200UR2014PTC001122.
Almonair Laboratories Private Limited is headquartered at Village Lamra Shimla Bahadur, Rudrapur, Uttarakhand, 263153.
Almonair Laboratories Private Limited was incorporated on 10 April 2014.
The current directors of Almonair Laboratories Private Limited are
The primary industry of Almonair Laboratories Private Limited is Trade.
Almonair Laboratories Private Limited is unlisted.
The authorized capital of Almonair Laboratories Private Limited is ₹1.00 M, and the paid-up capital is ₹0.65 M.
The compliance status of Almonair Laboratories Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX